Essia Mezni - Publications

Pharmacology and pharmacokinetics of antibody-drug conjugates, where do we stand?

Journal: Cancer treatment reviews

Published: January 24, 2025

Facial palsy after administration of immune checkpoint inhibitors: case report, literature review and clinical care management.

Journal: Frontiers in immunology

Published: January 23, 2024

Prevention of aromatase inhibitor-induced bone loss with anti-resorptive therapy in post-menopausal women with early-stage breast cancer.

Journal: Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA

Published: August 02, 2022

Immunotherapy and breast cancer: an overview.

Journal: Current opinion in oncology

Published: July 15, 2022

Updates in hormone-receptor-positive, human epidermal growth factor receptor 2 (HER2)-negative advanced breast cancer in 2021

Journal: Bulletin du cancer

Published: December 02, 2021

Impact of local treatment on survival from hematological malignancies causing spinal cord compression.

Journal: Surgical neurology international

Published: August 30, 2020

Combining poly(ADP-ribose) polymerase inhibitors and immune checkpoint inhibitors in breast cancer: rationale and preliminary clinical results.

Journal: Current opinion in oncology

Published: August 28, 2020

New Therapeutics in HER2-Positive Advanced Breast Cancer: Towards a Change in Clinical Practices?pi.

Journal: Cancers

Published: May 12, 2020

Two years survival of primary cardiac leiomyosarcoma managed by surgical and adjuvant therapy.

Journal: Clinical sarcoma research

Published: September 16, 2016